Intravenous Ganaxolone for the Treatment of Refractory Status Epilepticus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Epilepsia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial
Epilepsia 2022 Jun 24;[EPub Ahead of Print], H Vaitkevicius, RE Ramsay, CB Swisher, AM Husain, A Aimetti, M GasiorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.